Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

By KATIE THOMAS and CHARLES ORNSTEIN via NYT Health https://ift.tt/2xOKzCv With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards. The New York Times